NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/20/2024
Back to search
Official data from USPTO
ANKTIVA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
04/10/2026
Trademark type
Word
Nice classes
5
Filing date
09/01/2022
Registration date
02/20/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/20/2024
Last transaction
04/10/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
01/18/2022
First use in commerce
07/19/2022
Drawing code
4
Owner type
16
Owner location
Culver City, CA, US
Examiner
BARQUET-HORNBACK, ELENA M
Law office
O10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Altor BioScience, LLC
Representatives
Michael J. McCue LEWIS ROCA ROTHGERBER CHRISTIE LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the treatment of human diseases and animal diseasescancernon-cancerous neoplasiaimmunologic-related diseasesimmunologic dysfunctioninfectionsinfectious diseases for clinicalmedicinaltherapeuticvaccine and vaccine adjuvant purposes; pharmaceutical preparations and substances for the prevention of human diseases and animal diseasescancernon-cancerous neoplasiaimmunologic-related diseasesimmunologic dysfunctioninfectionsinfectious diseasesfor clinicalmedicinaltheapeuticvaccinevaccine adjuvant purposes; pharmaceutical and biological preparations for use in targeted immunotherapy for the treatment of human diseases and animal diseasescancerinfectious diseases; biological preparations for medical purposesin the fields of immunotherapyimmuno-oncology; anti-infectives for medical use for the treatment of human diseases and animal diseasescancernon-cancerous neoplasiaimmunologic-related diseasesimmunologic dysfunctioninfectionsinfectious diseases
Publications
History of USPTO decisions and trademark events.
15 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/20/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/05/2023
PUBO
PUBLISHED FOR OPPOSITION
12/05/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/15/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/31/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/24/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/23/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/23/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/17/2023
GNRT
NON-FINAL ACTION E-MAILED
06/17/2023
CNRT
NON-FINAL ACTION WRITTEN
06/17/2023
DOCK
ASSIGNED TO EXAMINER
06/16/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/21/2022
NWAP
NEW APPLICATION ENTERED
09/05/2022
Continuous trademark protection
Get notified about every new filing that threatens ANKTIVA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.